JP2013503192A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503192A5
JP2013503192A5 JP2012527033A JP2012527033A JP2013503192A5 JP 2013503192 A5 JP2013503192 A5 JP 2013503192A5 JP 2012527033 A JP2012527033 A JP 2012527033A JP 2012527033 A JP2012527033 A JP 2012527033A JP 2013503192 A5 JP2013503192 A5 JP 2013503192A5
Authority
JP
Japan
Prior art keywords
residues
antigen
binding fragment
monoclonal antibody
mip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012527033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503192A (ja
JP6109571B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047004 external-priority patent/WO2011025962A1/en
Publication of JP2013503192A publication Critical patent/JP2013503192A/ja
Publication of JP2013503192A5 publication Critical patent/JP2013503192A5/ja
Application granted granted Critical
Publication of JP6109571B2 publication Critical patent/JP6109571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012527033A 2009-08-28 2010-08-27 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体 Active JP6109571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23801509P 2009-08-28 2009-08-28
US61/238,015 2009-08-28
PCT/US2010/047004 WO2011025962A1 (en) 2009-08-28 2010-08-27 Antikine antibodies that bind to multiple cc chemokines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016011829A Division JP2016135783A (ja) 2009-08-28 2016-01-25 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体

Publications (3)

Publication Number Publication Date
JP2013503192A JP2013503192A (ja) 2013-01-31
JP2013503192A5 true JP2013503192A5 (enExample) 2013-09-19
JP6109571B2 JP6109571B2 (ja) 2017-04-05

Family

ID=43628404

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012527033A Active JP6109571B2 (ja) 2009-08-28 2010-08-27 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体
JP2016011829A Pending JP2016135783A (ja) 2009-08-28 2016-01-25 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016011829A Pending JP2016135783A (ja) 2009-08-28 2016-01-25 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体

Country Status (18)

Country Link
US (3) US8313747B2 (enExample)
EP (1) EP2470671B1 (enExample)
JP (2) JP6109571B2 (enExample)
KR (1) KR101778813B1 (enExample)
CN (1) CN102782148B (enExample)
AU (1) AU2010286516B2 (enExample)
BR (1) BR112012004387A2 (enExample)
CA (1) CA2771781C (enExample)
DK (1) DK2470671T3 (enExample)
ES (1) ES2531561T3 (enExample)
HR (1) HRP20150162T1 (enExample)
IN (1) IN2012DN01769A (enExample)
MX (1) MX2012002427A (enExample)
PL (1) PL2470671T3 (enExample)
PT (1) PT2470671E (enExample)
SI (1) SI2470671T1 (enExample)
SM (1) SMT201500011B (enExample)
WO (1) WO2011025962A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN01769A (enExample) * 2009-08-28 2015-06-05 Vlst Corp
EP3693041A1 (en) * 2011-06-13 2020-08-12 TLA Targeted Immunotherapies AB Treating cancer
WO2013033206A2 (en) * 2011-08-29 2013-03-07 University Of Rochester Compositions and methods for inhibiting ccl3
EP2763540A4 (en) * 2011-09-09 2015-04-22 Univ Yale COMPOSITIONS AND METHODS FOR THE EVALUATION AND TREATMENT OF INFLAMMATORY DISEASES AND DISEASES
PL3489261T3 (pl) 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
TWI612059B (zh) * 2013-03-15 2018-01-21 美國禮來大藥廠 泛－ＥＬＲ<sup>＋</sup>ＣＸＣ趨化因子抗體
EA201591993A1 (ru) * 2013-05-23 2016-05-31 Шир Хьюман Дженетик Терапис, Инк. Лечение склеродермии с применением комбинированной терапии антителами анти-ccl2 и анти-loxl2
JP6220222B2 (ja) * 2013-10-28 2017-10-25 シスメックス株式会社 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品
KR20210125114A (ko) * 2013-12-09 2021-10-15 알라코스 인크. 항-Siglec-8 항체 및 그의 사용 방법
JP6825909B2 (ja) 2014-02-28 2021-02-03 アラコス インコーポレイテッド シグレック−８関連疾患を処置するための方法および組成物
US10246508B2 (en) * 2014-03-04 2019-04-02 Chemomab Ltd. Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
CN104198727A (zh) * 2014-08-22 2014-12-10 广西南宁隆吉维特生物科技有限公司 人血清ccl2酶联免疫检测试剂盒及其制备和使用方法
TWI566780B (zh) * 2014-10-24 2017-01-21 國立陽明大學 巨噬細胞發炎蛋白－１β（ＭＩＰ－１β）抑制劑用於促進血管新生以改善組織缺血及糖尿病血管病變的用途
ES2841353T3 (es) 2014-12-09 2021-07-08 Regeneron Pharma Animales no humanos que tienen un gen del grupo de diferenciación 274 humanizado
HK1254432A1 (zh) 2015-06-17 2019-07-19 Allakos Inc. 用於治疗纤维性疾病的方法和组合物
US10604577B2 (en) 2015-10-22 2020-03-31 Allakos Inc. Methods and compositions for treating systemic mastocytosis
KR20230047507A (ko) 2016-06-27 2023-04-07 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 암 치료 조합
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
CA3045310A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
WO2018159787A1 (ja) * 2017-03-01 2018-09-07 国立大学法人北海道大学 疾患モデル非ヒト動物の製造方法、疾患モデル非ヒト動物、該動物を用いた薬剤のスクリーニング方法及び疾患リスク判定方法
KR102009040B1 (ko) * 2017-04-05 2019-08-08 한국생명공학연구원 Nk 세포 활성화 융합 단백질, nk 세포 및 이들을 포함하는 약제학적 조성물
BR112019022912A2 (pt) 2017-05-05 2020-05-26 Allakos Inc. Métodos e composições para tratar doenças oculares alérgicas
WO2019037067A1 (zh) * 2017-08-25 2019-02-28 法玛科技顾问股份有限公司 巨噬细胞发炎蛋白-1β(MIP-1β)抑制剂用以治疗及控管动脉粥状硬化的用途
CN111801353B (zh) * 2017-10-13 2024-09-17 A&G药品公司 针对前列腺素f2受体抑制剂的单克隆抗体和缀合物及其用途
WO2019133902A2 (en) * 2017-12-28 2019-07-04 Astute Medical, Inc. Antibodies and assays for ccl14
WO2019165397A1 (en) * 2018-02-26 2019-08-29 Cornell University Quantitative biomarkers of ehv-1 susceptibility and protection
WO2019217705A1 (en) * 2018-05-11 2019-11-14 Proplex Technologies, LLC Binding proteins and chimeric antigen receptor t cells targeting gasp-1 granules and uses thereof
CN113348011B (zh) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN110117329B (zh) * 2019-04-03 2020-12-08 河北浓孚雨生物科技有限公司 包含趋化因子与结合伴侣的融合多肽及其用途
CN114341178B (zh) * 2019-07-02 2024-05-07 机敏医药股份有限公司 Ccl14的抗体和检测
KR102489282B1 (ko) * 2019-07-02 2023-01-17 고려대학교 산학협력단 Ccl4, ccl5, ccl20, 및 ccl21을 유효성분으로 포함하는 임신촉진용 조성물
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN113893331B (zh) * 2020-07-06 2024-11-26 中国农业科学院特产研究所 一种诱导母鹿生茸的产品及其制备方法和诱导母鹿生茸的方法和应用
EP4178614A4 (en) * 2020-07-08 2024-10-30 Georgia Tech Research Corporation COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF SARS-COV-2 VIRUS INFECTIONS
AU2021277712B2 (en) * 2020-10-16 2023-05-25 LaNova Medicines Limited Anti-CCR8 monoclonal antibodies and uses thereof
CN115598111B (zh) * 2021-07-08 2025-03-25 南京大学 基于邻位诱导免疫分析的特异性杂交瘤细胞化学发光筛选方法
CN114990073A (zh) * 2022-05-27 2022-09-02 河南农业大学 一种抗猪ccl2蛋白的单克隆抗体及其制备方法和应用
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
US6498015B1 (en) * 1995-06-07 2002-12-24 Icos Corporation Methods of identifying agents that modulate the binding between MDC and an MDC receptor
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6316420B1 (en) * 1998-07-28 2001-11-13 Technion Research And Development Foundation Ltd. DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis
US6420346B1 (en) * 2000-02-07 2002-07-16 Rappaport Family Institute For Research In The Medical Sciences Polynucleotides encoding MIP-1α, MCP-1, MIP-1β, Rantes and TNF-α, and methods for treating rheumatoid arthritis
EP1542724A4 (en) 2002-08-19 2005-10-19 Abgenix Inc ANTIBODIES AGAINST THE MONOCYTE 1 CHIMIOATTRACTIVE PROTEIN (MCP-1) AND USES THEREOF
CA2507080C (en) 2002-11-27 2015-01-06 Biogen Idec Ma Inc. Humanized antibodies against monocyte chemotactic proteins
EP1828234B1 (en) * 2004-12-21 2009-03-25 Laboratoires Serono S.A. Cc-chemokine antagonists
EP2185719B1 (en) * 2007-08-02 2013-11-13 NovImmune SA Anti-rantes antibodies and methods of use thereof
IN2012DN01769A (enExample) * 2009-08-28 2015-06-05 Vlst Corp

Similar Documents

Publication Publication Date Title
HRP20150162T1 (hr) Antikin antitijela koja se vežu na višestruke cc kemokine
RU2474588C2 (ru) Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
EP2890711B1 (en) Method for producing antibody molecules having inter-species, intra-target cross-reactivity
JP2010526028A5 (enExample)
RU2011149334A (ru) Анти-il-17f антитела и способы их применения
JP2013538057A5 (enExample)
JP2013545438A5 (enExample)
RU2015111563A (ru) Способы лечения патологических состояний антителами, которые связываются с рецептором колониестимулирующего фактора 1 (csf1r)
JP2012531922A5 (ja) Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位
JP2014526898A5 (enExample)
JP2007262074A5 (enExample)
JP2013198490A5 (enExample)
JP2011520898A5 (enExample)
JP2014500009A5 (enExample)
RU2010132647A (ru) Анти-mif антитела
RU2016136639A (ru) Антитела против эотаксина 2, которые распознают дополнительные связывающие CCR3 хемокины
HRP20170254T1 (hr) Humanizirana i kimerna monoklonska protutijela usmjerena na cd47
JP2012143232A5 (enExample)
JP2016505556A5 (enExample)
NZ712762A (en) Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
HRP20191342T1 (hr) Anti-phf-tau antitijela i njihove upotrebe
JP2010527939A5 (enExample)
JP2015028021A5 (enExample)
JP2012501670A5 (enExample)
JP2017508461A5 (enExample)